Bangladesh, Nepal among 13 nations to get anti-malarial drug from India

Photo: Collected

Union Government has approved the first list of countries that will receive crucial COVID-fighting drugs from India, including the much talked about anti-malaria drug, hydroxychloroquine or HCQ. The first consignment has started to leave.

The list includes 13 countries including the United States of America, Spain, Germany, Bahrain, Brazil, Nepal, Bhutan, Afghanistan, Maldives, Bangladesh, india, Mauritius and the Dominican Republic.

They said that the US had asked for 48 lakh tablets of HCQ and India has sanctioned 35.82 lakh tablets, sources said.

They said that the US had asked for 48 lakh tablets of HCQ and India has sanctioned 35.82 lakh tablets, sources said.

Hydroxychloroquine is an anti-malarial drug deemed to be useful in dealing with COVID-19.

The sources said that India has also sent nine MT of Active Pharmaceutical Ingredient (API) to the US in line with its request.

They said Brazil and Canada are expected to get 50 lakh tablets of hydroxychloroquine in the second consignment. In the first consignment, Brazil will receive 0.53 MT of API.

The sources said Bangladesh will get 20 lakh tablets of hydroxychloroquine, Nepal 10 lakh, Bhutan 2 lakh, Sri Lanka 10 lakh (not in the first consignment), Afghanistan 5 lakh, and Maldives 2 lakh.

The sources said India will be sending a total of 14 million tablets and 13.5 MT API.

US President Donald Trump on Wednesday thanked Prime Minister Narendra Modi for allowing the export of HCQ. In a tweet he had also thanked India and the Indian people for the decision on HCQ, saying it will not be forgotten.

Israeli Prime Minister Benjamin Netanyahu also thanked India for sending chloroquine.